EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation

Yun Gi Kim, Hyoung Seok Lee iD, Hoseob Kim iD, Mina Kim iD, Joo Hee Jeong iD, Yun Young Choi, Jaemin Shim iD, Jong-Il Choi iD, Young-Hoon Kim

Journal of Clinical Medicine · 11.02.2025 · 14 (4) · 1168

DOI: 10.3390/jcm14041168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.02.2025. Verfasst von Yun Gi Kim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul 02708, Republic …. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea University Grant (J-I.C), a grant from Korea University Anam Hospital, Seoul, Republic of Korea (J-I.C), and in part by a National Research Foundation of…, Korea University, Korea University Anam Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims: Antiarrhythmic drugs (AADs) are the primary treatment for maintaining sinus rhythm in patients with atrial fibrillation (AF). While amiodarone is mainly used in patients with structural heart disease, its effects on all-cause mortality compared to other AADs remain unclear.

Methods

This study utilized nationwide healthcare insurance data involving patients with new-onset AF from 2013 to 2019. We identified patients who were prescribed with AADs ≥ six months within the first year of diagnosis (medication possession ratio ≥ 0.5). All-cause mortality was assessed between amiodarone and other AAD users up to three years post-AAD-prescription.

Results

Among 770,977 new-onset AF patients, 12,243 were amiodarone users and 33,036 were prescribed with other AADs. Significant differences in mean age and prevalence of medical conditions such as heart failure, myocardial infarction, chronic kidney disease, diabetes, and dyslipidemia were noted. After propensity score matching, 12,017 amiodarone users were compared to an equal number of other AAD users with similar baseline characteristics. Multivariate analysis indicated a 2.9-fold increase in all-cause mortality for amiodarone users (hazard ratio = 2.88; 95% confidence interval = 2.64–3.15; p < 0.001). This increased risk was more pronounced among women compared with men (hazard ratio = 3.38 vs. 2.56; p for interaction = 0.004). Amiodarone was associated with increased mortality in AF patients with heart failure and myocardial infarction.

Conclusions

Amiodarone, compared with non-amiodarone AADs, was associated with increased risk of all-cause mortality in AAD-naive new-onset AF patients. Increased all-cause mortality associated with amiodarone was consistent throughout various subgroups. Significant interaction was observed with the sex category, with women being more vulnerable to amiodarone.

Schlagwörter

Stichwörter der Autor:innen

amiodaroneantiarrhythmic drugsatrial fibrillationmortality

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine, Korea University Anam Hospital, Seoul 02708, Republic of Korea.
  • Department of Data Science, Hanmi Pharm Co., Ltd., Seoul 05545, Republic of Korea.

ORCID-Profile: Hyoung Seok Lee, Hoseob Kim, Mina Kim, Joo Hee Jeong, Jaemin Shim, Jong-Il Choi

Förderung

  • Korea University Grant (J-I.C), a grant from Korea University Anam Hospital, Seoul, Republic of Korea (J-I.C), and in part by a National Research Foundation of…
  • Korea University
  • Korea University Anam Hospital
  • Korean government (MSIT, Ministry of Science and ICT)

Zitieren

APA

Kim, Y. G., Lee, H. S., Kim, H., Kim, M., Jeong, J. H., Choi, Y. Y., Shim, J., Choi, J. I., & Kim, Y. H. (2025). Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation. Journal of Clinical Medicine, 14(4), 1168. https://doi.org/10.3390/jcm14041168

Vancouver

Kim YG, Lee HS, Kim H, Kim M, Jeong JH, Choi YY, et al. Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation. Journal of Clinical Medicine. 2025;14(4):1168. doi:10.3390/jcm14041168

BibTeX
@article{Kim2025,
  author = {Kim, Yun Gi and Lee, Hyoung Seok and Kim, Hoseob and Kim, Mina and Jeong, Joo Hee and Choi, Yun Young and Shim, Jaemin and Choi, Jong-Il and Kim, Young-Hoon},
  title = {Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {1168},
  doi = {10.3390/jcm14041168}
}
Kostenlos starten →